Under the agreement, Sun Pharmaceutical Industries, Inc. and Taro will make a combined payment of $200 million in exchange for a full release of all claims brought against them by the End Purchaser Plaintiffs. Shares of Sun Pharmaceutical Industries Ltd ended at ₹1,692.10, up by ₹9.50, or 0.56%, on the BSE.
